Loading...
Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IX
The development of alloantibodies neutralising therapeutically administered factor (F) VIII/IX (inhibitors) is currently the most severe complication of the treatment of haemophilia. When persistent and at a high titre, inhibitors preclude the standard replacement treatment with FVIII/FIX concentrat...
Na minha lista:
| Udgivet i: | J Clin Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5406778/ https://ncbi.nlm.nih.gov/pubmed/28420167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm6040046 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|